Three Indiana University-led research innovations, designed to improve the treatment of Alzheimer’s disease and ovarian and other cancers, recently received patents from the U.S. Patent and Trademark Office. Below is information about each patent. Patent issued to small molecule inhibitors of ALDH for the treatment of epithelial ovarian cancer: The U.S. Patent and Trademark Office… Read more »
Tag: IU ICO
Patents awarded to four IU innovations
Four Indiana University-led technologies and methods, spanning the fields of electrical engineering, medicine and music, recently received patents from the U.S. Patent and Trademark Office. Below is information about each patent. Patent issued to IU innovation method for treating clinical conditions through the use of hematopoietic stem cells: The U.S. Patent and Trademark Office has… Read more »
IU researcher develops anticounterfeit tags and environmental sensors using nanoparticles
From apparel to pharmaceuticals, the global impact of counterfeit goods can reach up to $1.7 trillion annually across numerous markets. To tackle this important issue, Indiana University research chemist Sara Skrabalak is using nanoparticles to develop anticounterfeit tags and environmental sensors that mark critical components to confirm if an item has been tampered with. She… Read more »
IU researcher’s drone operating system looks to the future of transportation
With the use of drones on the rise, it is crucial to have an efficient management system to streamline drone deliveries that will meet growing transportation needs. Rudy Banerjee, an associate professor of geography at the Indiana University School of Liberal Arts in Indianapolis, has developed SkyDOS, a drone traffic management system that translates current… Read more »
IU researcher developing new pediatric leukemia therapies
Pediatric leukemia affects approximately 4,000 children each year in the United States, and the incidence of the disease is steadily increasing year after year. Reuben Kapur, director of the Herman B Wells Center for Pediatric Research at the Indiana University School of Medicine, is working to discover new treatments that will improve patient care. He… Read more »
IU researcher develops innovation to combat increasing mosquito insecticide resistance, mosquito-borne diseases
Mosquito-borne infectious diseases like malaria, which claims half a million lives a year, have been on the rise over the past several years and pose a significant threat to global health. Even with the availability of many viable chemistries, there is a pressing need for new and innovative solutions to address insecticide resistance, mitigate environmental… Read more »
IU researcher engineers data-processing architectures in fibers
To meet the demands of the Internet of Tomorrow, Indiana University researcher and entrepreneur Alexander Gumennik is advancing smart fibers that could lead to improvements in the management of biomedical and biohazardous materials, the monitoring of our environment and the human body, optical treatments and more. Gumennik is interested in collaborating with industry partners to… Read more »
Patents awarded to six IU innovations
Six Indiana University-led technologies and methods have recently received patents from the U.S. Patent and Trademark Office. These innovations include an antiviral drug treatment for HPV, as well as methods for activating T cells in vitro, processing speech, enhancing the study of the gut microbial ecosystem, analyzing lipoproteins through the use of mass spectrometry and… Read more »
IU researcher pioneers new class of antibiotics to treat infectious diseases
An Indiana University researcher is pioneering an innovative approach to develop new antibiotics that could help address the growing problem of bacterial antimicrobial resistance, which is when bacteria and viruses no longer respond to antibiotic medicines. Recent estimates indicate that each year there are 5 million infections globally associated with bacterial antimicrobial resistance, with 1.3… Read more »
IU researcher uses revolutionary method to develop anticancer therapeutics
When developing anticancer therapeutics, most researchers aim to kill cancerous cells. However, Hiroki Yokota’s approach is to control their growth by knowing how to grow them. Yokota, a professor of biomedical engineering at the School of Engineering and Technology at IUPUI, an adjunct professor of anatomy, cell biology and physiology at the IU School of… Read more »